Survival sex work involvement as a primary risk factor for hepatitis C virus acquisition in drug-using youths in a Canadian setting

Archives of Pediatrics and Adolescent Medicine

Volumn 164, Issue 1, 2010, Pages 61-65

  Shannon, Kate ^a   Kerr, Thomas ^a   Marshall, Brandon ^a   Li, Kathy ^a   Zhang, Ruth ^a   Strathdee, Steffanie A ^b   Tyndall, Mark W ^a   Montaner, Julio G S ^a   Wood, Evan ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CANADA; CONTROLLED STUDY; DRUG USE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE;

ADOLESCENT; ADULT; BRITISH COLUMBIA; FEMALE; HEPATITIS C; HOMELESS YOUTH; HUMANS; INCIDENCE; MALE; PREVALENCE; PROPORTIONAL HAZARDS MODELS; PROSTITUTION; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 73449148017     PISSN: 10724710     EISSN: 15383628     Source Type: Journal    
DOI: 10.1001/archpediatrics.2009.241     Document Type: Article

References (41)

1. World Health Organization. Hepatitis C fact sheet. http://www.who.int/ mediacentre/factsheets/fs164/en. Accessed January 18, 2009.
2. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558-567.
3. Des Jarlais DC, Arasteh K, McKnight C, Hagan H, Perlman D, Friedman SR. Using hepatitis C virus and herpes simplex virus-2 to track HIV among injecting drug users in New York City [published online ahead of print December 23, 2008]. Drug Alcohol Depend. 2009;101(1-2):88-91.
4. Thiede H, Hagan H, Campbell JV, et al; DUIT Study Team. Prevalence and correlates of indirect sharing practices among young adult injection drug users in five U.S. cities. Drug Alcohol Depend. 2007;91(suppl 1):S39-S47.
5. Tortu S, McMahon JM, Pouget ER, Hamid R. Sharing of noninjection drug-use implements as a risk factor for hepatitis C. Subst Use Misuse. 2004;39(2): 211-224.
6. Hagan H, Thiede H, Weiss NS, Hopkins SG, Duchin JS, Alexander ER. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am J Public Health. 2001;91(1):42-46.
7. De P, Roy E, Boivin J, Cox C, Morissette C. Risk of hepatitis C virus transmission through drug preparation equipment: a systematic and methodological review. J Viral Hepat. 2008;15(4):279-292.
8. Miller CL, Johnston C, Spittal PM, et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology. 2002;36(3):737-742.
9. Hagan H, Thiede H, Des Jarlais DC. Hepatitis C virus infection among injection drug users: survival analysis of time to seroconversion. Epidemiology. 2004; 15(5):543-549.
10. Maher L, Jalaludin B, Chant K, et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction. 2006;101(10): 1499-1508.
11. Judd A, Hickman M, Jones S, et al. Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ. 2005; 330(7481):24-25.
12. Hahn JA, Page-Shafer K, Lum PJ, et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J Infect Dis. 2002;186 (11):1558-1564.
13. Miller CL, Spittal PM, LaLiberte N, et al. Females experiencing sexual and drug vulnerabilities are at elevated risk for HIV infection among youth who use injection drugs. J Acquir Immune Defic Syndr. 2002;30(3):335-341.
14. Roy E, Haley N, Leclerc P, Cédras L, Blais L, Boivin JF. Drug injection among street youths in Montreal: predictors of initiation. J Urban Health. 2003;80 (1):92-105.
15. Rekart ML. Sex-work harm reduction. Lancet. 2005;366(9503):2123- 2134.
16. Strathdee SA, Philbin MM, Semple SJ, et al. Correlates of injection drug use among female sex workers in two Mexico-U.S. border cities. Drug Alcohol Depend. 2008; 92(1-3):132-140.
17. Goodyear MD, Cusick L. Protection of sex workers. BMJ. 2007;334(7584):52-53.
18. Shannon K, Rusch M, Shoveller J, Alexson D, Gibson K, Tyndall MW; Maka Project Partnership. Mapping violence and policing as an environmental- structural barrier to health service and syringe availability among substance-using women in street-level sex work. Int J Drug Policy. 2008;19(2):140-147.
19. Shannon K, Strathdee SA, Shoveller J, Rusch M, Kerr T, Tyndall MW. Structural and environmental barriers to condom use negotiation with clients among female sex workers: implications for HIV-prevention strategies and policy. Am J Public Health. 2009;99(4):659-665.
20. Shannon K, Kerr T, Strathdee SA, Shoveller J, Montaner JS, Tyndall MW. Prevalence and structural correlates of gender based violence among a prospective cohort of female sex workers. BMJ. 2009;339:b2939.
21. Strathdee SA, Patrick DM, Currie SL, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS. 1997;11(8):F59-F65.
22. Wood E, Kerr T, Lloyd-Smith E, et al. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J. 2004;1(1):9.
23. Kerr T, Tyndall MW, Li K, Montaner JS, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet. 2005;366(9482):316-318.
24. Wood E, Montaner JS, Li K, et al. Burden of HIV infection among aboriginal injection drug users in Vancouver, British Columbia. Am J Public Health. 2008; 98(3):515-519.
25. Centers for Disease Control and Prevention. National prevention strategy: a comprehensive strategy for the prevention and control of hepatitis C virus infection and its consequences. http://www.cdc.gov/hepatitis/HCV/Strategy/ NatHepCPrevStrategy.htm. Published Summer 2001. Accessed January 2009.
26. Kuyper LM, Lampinen TM, Li K, et al. Factors associated with sex trade involvement among male participants in a prospective study of injection drug users. Sex Transm Infect. 2004;80(6):531-535.
27. Kuyper LM, Palepu A, Kerr T, et al. Factors associated with sex-trade involvement among female injection drug users in a Canadian setting. Addict Res Theory. 2005;13(2):193-199.
28. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements. 2002;19(3):1-46.
29. Grund JP, Friedman SR, Stern LS, et al. Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med. 1996;42(5):691-703.
30. Sherman SG, Latkin CA, Gielen AC. Social factors related to syringe sharing among injecting partners: a focus on gender. Subst Use Misuse. 2001;36(14):2113-2136.
31. Rhodes T, Quirk A. Drug users' sexual relationships and the social organisation of risk: the sexual relationship as a site of risk management. Soc Sci Med. 1998; 46(2):157-169.
32. De P, Cox J, Boivin JF, Platt RW, Jolly AM. The importance of social networks in their association to drug equipment sharing among injection drug users: a review. Addiction. 2007;102(11):1730-1739.
33. Bourgois P, Prince B, Moss A. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Hum Organ. 2004;63(3):253-264.
34. Shannon K, Kerr T, Allinott S, Chettiar J, Shoveller JS, Tyndall MW. Social and structural violence and power relations in mitigating HIV risk of drug-using women in survival sex work. Soc Sci Med. 2008;66(4):911-921.
35. Bristol N. US Senate passes new PEPFAR bill. Lancet. 2008;372(9635):277-278.
36. Masenior NF, Beyrer C. The US anti-prostitution pledge: First Amendment challenges and public health priorities. PLoS Med. 2007;4(7):e207.
37. Shahmanesh M, Patel V, Mabey D, Cowan F. Effectiveness of interventions for the prevention of HIV and other sexually transmitted infections in female sex workers in resource poor setting: a systematic review. Trop Med Int Health. 2008; 13(5):659-679.
38. Sweat MD, Denison JA. Reducing HIV incidence in developing countries with structural and environmental interventions. AIDS. 1995;9(suppl A):S251-S257.
39. World Health Organization. Toolkit for Targeted HIV Prevention and Care in Sex Work Settings. Geneva, Switzerland: Department of HIV/AIDS, World Health Organization; 2005.
40. Roy E, Alary M, Morissette C, et al; SurvUDI Working Group. High hepatitis C virus prevalence and incidence among Canadian intravenous drug users. Int J STD AIDS. 2007;18(1):23-27.
41. Wood E, Schachar J, Li K, et al. Sex trade involvement is associated with elevated HIV incidence among injection drug users in Vancouver. Addict Res Theory. 2007;15(3):321-325.